Clinical Trials Browser

Phase 2 × Palivizumab × 1 year × Clear all

NCT01703754 2025-08-28

Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.

Phase 2 Terminated

12 enrolled 24 charts

Breast Neoplasms